SCHEMBL7991635

SCHEMBL7991635

Oc1cccc(-c2nc(O)c3c(ncn3Cc3cccc(F)c3)n2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.37
TDO2 P48775 1/20 0.37
HSD17B13 Q7Z5P4 2/20 0.37
CDK9 P50750 2/20 0.36
BRD4 O60885 1/20 0.36
EPHX2 P34913 1/20 0.36
PPARG P37231 1/20 0.36
MET P08581 1/20 0.36
CYP11B1 P15538 1/20 0.36
CYP11B2 P19099 1/20 0.36
MKNK1 Q9BUB5 1/20 0.35
MKNK2 Q9HBH9 1/20 0.35
ROCK2 O75116 1/20 0.35
ROCK1 Q13464 1/20 0.35
HSD17B1 P14061 1/20 0.35
HSD17B2 P37059 1/20 0.35
PIK3CA P42336 2/20 0.35
PIK3CG P48736 2/20 0.35
MTOR P42345 1/20 0.35
CNR1 P21554 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7991669 0.94 HDAC1 (0.38) HSD17B13CDK9BRD4EPHX2PPARG
SCHEMBL7985791 0.91 CYP11B1 (0.40) HSD17B13CDK9BRD4EPHX2PPARG
SCHEMBL7985299 0.90 CDK9 (0.39) HSD17B13CDK9BRD4EPHX2PPARG
SCHEMBL7985613 0.90 MET (0.46) IDO1TDO2HSD17B13METCYP11B1
SCHEMBL7985360 0.89 POLB (0.40) HSD17B13CDK9HDAC1HDAC6
SCHEMBL7987253 0.89 HPGDS (0.40) METCYP11B1CYP11B2HDAC1HDAC6
SCHEMBL7988638 0.89 MET (0.42) IDO1HSD17B13CDK9BRD4EPHX2
SCHEMBL7985336 0.89 PIK3CA (0.42) HSD17B13CYP11B1CYP11B2HSD17B1HSD17B2
SCHEMBL7988958 0.87 ALDH1A1 (0.42) BRD4METCYP11B1CYP11B2
SCHEMBL7987310 0.87 YTHDC1 (0.41) HSD17B13CDK9HDAC1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed